{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:43:53Z","timestamp":1788389033753,"version":"build-2803163510"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100022817","name":"Lanzhou University Second Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022817","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["24JRRA3221"],"award-info":[{"award-number":["24JRRA3221"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["CY2024-MS-B04"],"award-info":[{"award-number":["CY2024-MS-B04"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.critrevonc.2026.105355","type":"journal-article","created":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T21:02:04Z","timestamp":1777842124000},"page":"105355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Efferocytosis as a Metabolic Rheostat: The Metabolic Bridge connecting TKI-induced cell death to immune tolerance in hepatocellular carcinoma"],"prefix":"10.1016","volume":"223","author":[{"given":"Xiyang","family":"Sheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gengyuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyue","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanteng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105355_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.imlet.2018.05.001","article-title":"Targeting the CD73-adenosine axis in immuno-oncology","volume":"205","author":"Allard","year":"2019","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.critrevonc.2026.105355_bib2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1053\/j.gastro.2014.11.045","article-title":"Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK","volume":"148","author":"Bernsmeier","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.critrevonc.2026.105355_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104776","article-title":"Cancer in a drop: advances in liquid biopsy in 2024","volume":"213","author":"Borea","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.critrevonc.2026.105355_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000417","article-title":"Small molecule AZD4635 inhibitor of A2AR signaling rescues immune cell function including CD103+ dendritic cells enhancing anti-tumor immunity","volume":"8","author":"Borodovsky","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105355_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/OV.S59640","article-title":"The emerging therapeutic potential of the oncolytic immunotherapeutic Pexa-Vec (JX-594)","author":"Breitbach","year":"2015","journal-title":"OV"},{"key":"10.1016\/j.critrevonc.2026.105355_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature10358","article-title":"Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans","volume":"477","author":"Breitbach","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105355_bib7","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105355_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001375","article-title":"Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47","volume":"2","author":"Chao","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105355_bib9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13045-024-01647-1","article-title":"Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, clinical efficacy, and future perspectives","volume":"17","author":"Chen","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105355_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00262-025-04089-x","article-title":"Characteristics and outcomes of primary and secondary resistance to immune checkpoint inhibitors in hepatocellular carcinoma","volume":"74","author":"Cui","year":"2025","journal-title":"Cancer Immunology Immunotherapy CII"},{"key":"10.1016\/j.critrevonc.2026.105355_bib11","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105355_bib12","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41577-019-0240-6","article-title":"Efferocytosis in health and disease","volume":"20","author":"Doran","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105355_bib13","article-title":"Metabolic programming and immune suppression in the tumor microenvironment","volume":"41","author":"En","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.critrevonc.2026.105355_bib14","doi-asserted-by":"crossref","DOI":"10.1172\/JCI1112","article-title":"Macrophages That Have Ingested Apoptotic Cells In Vitro Inhibit Proin\ufb02ammatory Cytokine Production Through Autocrine\/Paracrine Mechanisms Involving TGF-b, PGE2, and PAF","author":"Fadok","year":"1998","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.critrevonc.2026.105355_bib15","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.critrevonc.2026.105355_bib16","doi-asserted-by":"crossref","DOI":"10.1177\/10732748251406674","article-title":"Macrophage Polarization in the Tumor Microenvironment of Hepatocellular Carcinoma: From Mechanistic Insights to Translational Therapies","volume":"32","author":"Fu","year":"2025","journal-title":"Cancer Control"},{"key":"10.1016\/j.critrevonc.2026.105355_bib17","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3390\/cells10051208","article-title":"Immunology of Cell Death in Cancer Immunotherapy","volume":"10","author":"Galluzzi","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.critrevonc.2026.105355_bib18","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.critrevonc.2026.105355_bib19","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.3390\/cancers16233944","article-title":"Resistance to Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma (HCC): Clinical Implications and Potential Strategies to Overcome the Resistance","volume":"16","author":"Gawi Ermi","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105355_bib20","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity","volume":"167","author":"Geiger","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105355_bib21","doi-asserted-by":"crossref","DOI":"10.4161\/onci.28518","article-title":"Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death","volume":"3","author":"Golden","year":"2014","journal-title":"OncoImmunology"},{"key":"10.1016\/j.critrevonc.2026.105355_bib22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12943-024-02140-6","article-title":"Artificial intelligence alphafold model for molecular biology and drug discovery: a machine-learning-driven informatics investigation","volume":"23","author":"Guo","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105355_bib23","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.cell.2005.12.039","article-title":"CRIg: A Macrophage Complement Receptor Required for Phagocytosis of Circulating Pathogens","volume":"124","author":"Helmy","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105355_bib24","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.7150\/ijbs.102706","article-title":"Unveiling the Role of Mechanical Microenvironment in Hepatocellular Carcinoma: Molecular Mechanisms and Implications for Therapeutic Strategies","volume":"20","author":"Hong","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105355_bib25","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220681","article-title":"Lysosomal cholesterol overload in macrophages promotes liver fibrosis in a mouse model of NASH","volume":"220","author":"Itoh","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.critrevonc.2026.105355_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217472","article-title":"Drug resistance in TKI therapy for hepatocellular carcinoma: Mechanisms and strategies","volume":"613","author":"Jiang","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105355_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2026.116464","article-title":"Advancing cancer diagnosis and therapy: MXene-based biosensing and nanomedicine applications","volume":"176","author":"Kamyab","year":"2026","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.critrevonc.2026.105355_bib28","article-title":"Advances in green synthesis of nanoparticles for biomedical applications: Antimicrobial, antiviral, and cancer therapies","volume":"33","author":"Kamyab","year":"2026","journal-title":"Mater. Today Sustain."},{"key":"10.1016\/j.critrevonc.2026.105355_bib29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nature24028","article-title":"Discovery of a selective catalytic p300\/CBP inhibitor that targets lineage-specific tumours","volume":"550","author":"Lasko","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105355_bib30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41577-019-0167-y","article-title":"How macrophages deal with death","volume":"19","author":"Lemke","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105355_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40425-018-0360-8","article-title":"Targeting adenosine for cancer immunotherapy","volume":"6","author":"Leone","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105355_bib32","article-title":"Tumor-associated macrophages in anti-PD-1\/PD-L1 immunotherapy for hepatocellular carcinoma: recent research progress","volume":"15","author":"Li","year":"2024","journal-title":"Front. Pharm."},{"key":"10.1016\/j.critrevonc.2026.105355_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1696113","article-title":"The impact of metabolic reprogramming in hepatocellular carcinoma on T cell","volume":"16","author":"Liao","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105355_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1691297","article-title":"Role of the Wnt\/\u03b2-catenin signaling pathway in the development of HCC","volume":"16","author":"Lin","year":"2025","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2026.105355_bib35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-0038-1673621","article-title":"Immunomodulatory Effects of Current Targeted Therapies on Hepatocellular Carcinoma: Implication for the Future of Immunotherapy","volume":"38","author":"Lin","year":"2018","journal-title":"Semin Liver Dis."},{"key":"10.1016\/j.critrevonc.2026.105355_bib36","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/hep.27859","article-title":"Nuclear factor kappa B\u2013mediated CD47 up-regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice","volume":"62","author":"Lo","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.critrevonc.2026.105355_bib37","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/ijc.28159","article-title":"Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib","volume":"133","author":"Louandre","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105355_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009165","article-title":"Understanding the dynamics of TKI-induced changes in the tumor immune microenvironment for improved therapeutic effect","volume":"12","author":"Lu","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105355_bib39","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/15384101.2024.2309020","article-title":"The sorafenib resistance-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma","volume":"23","author":"Luo","year":"2024","journal-title":"Cell Cycle"},{"key":"10.1016\/j.critrevonc.2026.105355_bib40","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10565-025-10025-7","article-title":"Lipotoxicity, lipid peroxidation and ferroptosis: a dilemma in cancer therapy","volume":"41","author":"Ma","year":"2025","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.critrevonc.2026.105355_bib41","doi-asserted-by":"crossref","DOI":"10.1172\/JCI126089","article-title":"Myeloid cell\u2013derived PROS1 inhibits tumor metastasis by regulating inflammatory and immune responses via IL-10","volume":"131","author":"Maimon","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.critrevonc.2026.105355_bib42","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.3390\/cancers13174334","article-title":"Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for Immunotherapy","volume":"13","author":"Maravelia","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105355_bib43","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","article-title":"An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells","volume":"185","author":"Mezrich","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105355_bib44","doi-asserted-by":"crossref","DOI":"10.4251\/wjgo.v17.i4.101528","article-title":"Hepatocellular carcinoma resistance to tyrosine kinase inhibitors: Current status and perspectives","volume":"17","author":"Miao","year":"2025","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105355_bib45","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41586-018-0735-5","article-title":"Efferocytosis induces a novel SLC program to promote glucose uptake and lactate release","volume":"563","author":"Morioka","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105355_bib46","article-title":"Dielectrophoresis-based microfluidics for detection and separation of circulating tumor cells","volume":"9","author":"Najafipour","year":"2025","journal-title":"Sens. Actuators Rep."},{"key":"10.1016\/j.critrevonc.2026.105355_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104910","article-title":"Targeting cancer metabolism: Therapeutic potential of the fatty acid synthase (FASN) inhibitors","volume":"214","author":"Nuzzo","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.critrevonc.2026.105355_bib48","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O\u2019Neill","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105355_bib49","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC","volume":"592","author":"Pfister","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105355_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003311","article-title":"Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy","volume":"9","author":"Pinato","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105355_bib51","doi-asserted-by":"crossref","first-page":"9464","DOI":"10.1038\/s41467-024-53706-3","article-title":"Prostaglandin E2-EP2\/EP4 signaling induces immunosuppression in human cancer by impairing bioenergetics and ribosome biogenesis in immune cells","volume":"15","author":"Punyawatthananukool","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105355_bib52","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012345","article-title":"Targeting SQLE-mediated cholesterol metabolism to enhance CD8+ T cell activation and immunotherapy efficacy in hepatocellular carcinoma","volume":"13","author":"Qiao","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105355_bib53","doi-asserted-by":"crossref","first-page":"7570","DOI":"10.1158\/0008-5472.CAN-10-1267","article-title":"AXL Is an Essential Factor and Therapeutic Target for Metastatic Ovarian Cancer","volume":"70","author":"Rankin","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105355_bib54","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S1470-2045(21)00252-7","article-title":"Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2\u20133 study","volume":"22","author":"Ren","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2026.105355_bib55","doi-asserted-by":"crossref","first-page":"21123","DOI":"10.1074\/jbc.M110675200","article-title":"Regulation of T Cell Receptor CD3\u03b6 Chain Expression byl-Arginine","volume":"277","author":"Rodriguez","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.critrevonc.2026.105355_bib56","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.cell.2007.10.034","article-title":"TAM Receptors Are Pleiotropic Inhibitors of the Innate Immune Response","volume":"131","author":"Rothlin","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105355_bib57","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1158\/2159-8290.CD-19-0074","article-title":"\u03b2-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma","volume":"9","author":"Ruiz de Galarreta","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2026.105355_bib58","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41417-024-00764-w","article-title":"Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications","volume":"31","author":"Safri","year":"2024","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.critrevonc.2026.105355_bib59","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.3390\/biomedicines12122684","article-title":"Metabolic Crossroad Between Macrophages and Cancer Cells: Overview of Hepatocellular Carcinoma","volume":"12","author":"Santarsiero","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.critrevonc.2026.105355_bib60","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.immuni.2020.04.001","article-title":"Niche-Specific Reprogramming of Epigenetic Landscapes Drives Myeloid Cell Diversity in Nonalcoholic Steatohepatitis","volume":"52","author":"Seidman","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.critrevonc.2026.105355_bib61","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13046-025-03416-5","article-title":"Research progress of CD73-adenosine signaling regulating hepatocellular carcinoma through tumor microenvironment","volume":"44","author":"Shan","year":"2025","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.critrevonc.2026.105355_bib62","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s42255-024-01003-0","article-title":"Futile lipid cycling: from biochemistry to physiology","volume":"6","author":"Sharma","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.critrevonc.2026.105355_bib63","article-title":"Efferocytosis in liver disease","volume":"6","author":"Shi","year":"2024","journal-title":"JHEP Rep."},{"key":"10.1016\/j.critrevonc.2026.105355_bib64","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/s42255-024-01115-7","article-title":"Efferocytosis drives a tryptophan metabolism pathway in macrophages to promote tissue resolution","volume":"6","author":"Sukka","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.critrevonc.2026.105355_bib65","article-title":"Adenosine-A2A Receptor Pathway in Cancer Immunotherapy","volume":"13","author":"Sun","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105355_bib66","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s12967-025-06468-5","article-title":"GPX2 inhibition enhances antitumor efficacy of lenvatinib via promoting immunogenic cell death in hepatocellular carcinoma","volume":"23","author":"Tan","year":"2025","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.critrevonc.2026.105355_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202203973","article-title":"Targeted xCT-mediated Ferroptosis and Protumoral Polarization of Macrophages Is Effective against HCC and Enhances the Efficacy of the Anti-PD-1\/L1 Response","volume":"10","author":"Tang","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.critrevonc.2026.105355_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.991052","article-title":"Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechanistic insights","volume":"13","author":"Tian","year":"2022","journal-title":"Front. Pharm."},{"key":"10.1016\/j.critrevonc.2026.105355_bib69","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/gutjnl-2016-313615","article-title":"MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure","volume":"67","author":"Triantafyllou","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.critrevonc.2026.105355_bib70","doi-asserted-by":"crossref","first-page":"11103","DOI":"10.1073\/pnas.1305569110","article-title":"Anti-CD47 antibody\u2013mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response","volume":"110","author":"Tseng","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.critrevonc.2026.105355_bib71","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10238-024-01397-x","article-title":"Long non-coding RNAs in ferroptosis and cuproptosis impact on prognosis and treatment in hepatocellular carcinoma","volume":"24","author":"Wang","year":"2024","journal-title":"Clin. Exp. Med"},{"key":"10.1016\/j.critrevonc.2026.105355_bib72","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00281-018-0698-5","article-title":"Efferocytosis in the tumor microenvironment","volume":"40","author":"Werfel","year":"2018","journal-title":"Semin Immunopathol."},{"key":"10.1016\/j.critrevonc.2026.105355_bib73","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nrd2130","article-title":"Discovery and development of sorafenib: a multikinase inhibitor for treating cancer","volume":"5","author":"Wilhelm","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.critrevonc.2026.105355_bib74","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41419-024-06493-0","article-title":"Targeting AXL induces tumor-intrinsic immunogenic response in tyrosine kinase inhibitor-resistant liver cancer","volume":"15","author":"Xie","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.critrevonc.2026.105355_bib75","doi-asserted-by":"crossref","first-page":"615","DOI":"10.21037\/jgo.2016.03.10","article-title":"The prognostic role of lactate dehydrogenase serum levels in patients with hepatocellular carcinoma who are treated with sorafenib: the influence of liver fibrosis","volume":"7","author":"Yada","year":"2016","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105355_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1677028","article-title":"Metabolic reprogramming in efferocytosis","volume":"13","author":"Yan","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.critrevonc.2026.105355_bib77","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1136\/gutjnl-2014-307671","article-title":"Tim-3 fosters HCC development by enhancing TGF-\u03b2-mediated alternative activation of macrophages","volume":"64","author":"Yan","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.critrevonc.2026.105355_bib78","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nature17412","article-title":"Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism","volume":"531","author":"Yang","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105355_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1697008","article-title":"Lactylation in cancer: mechanistic insights, tumor microenvironment, and therapeutic horizons","volume":"16","author":"Yang","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105355_bib80","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1007\/s12672-025-04001-0","article-title":"Cancer immunotherapy by adenosinergic CD39 and CD73 as emerging immune checkpoints","volume":"16","author":"Yin","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105355_bib81","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/ni.2986","article-title":"Diversification of TAM receptor tyrosine kinase function","volume":"15","author":"Zag\u00f3rska","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105355_bib82","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41419-025-07359-9","article-title":"Histone lactylation promotes multidrug resistance in hepatocellular carcinoma by forming a positive feedback loop with PTEN","volume":"16","author":"Zeng","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.critrevonc.2026.105355_bib83","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1038\/s41467-019-11911-5","article-title":"Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105355_bib84","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105355_bib85","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cmet.2018.12.004","article-title":"Efferocytosis fuels requirements of fatty acid oxidation and the electron transport chain to polarize macrophages for tissue repair","volume":"29","author":"Zhang","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.critrevonc.2026.105355_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103826","article-title":"Macrophages and macrophage extracellular vesicles confer cancer ferroptosis resistance via PRDX6-mediated mitophagy inhibition","volume":"86","author":"Zheng","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.critrevonc.2026.105355_bib87","doi-asserted-by":"crossref","DOI":"10.1002\/smsc.202400479","article-title":"Targeting frequent efferocytosis in tumor microenvironment is a new direction for cancer treatment","volume":"5","author":"Zhu","year":"2025","journal-title":"Small Sci."},{"key":"10.1016\/j.critrevonc.2026.105355_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/gad.1376506","article-title":"Necrotic death as a cell fate","volume":"20","author":"Zong","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.critrevonc.2026.105355_bib89","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.it.2024.05.002","article-title":"Macrophages marc(o) the difference in liver inflammation?","volume":"45","author":"Zwicker","year":"2024","journal-title":"Trends Immunol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826002428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826002428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T14:41:10Z","timestamp":1783176070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826002428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":89,"alternative-id":["S1040842826002428"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105355","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efferocytosis as a Metabolic Rheostat: The Metabolic Bridge connecting TKI-induced cell death to immune tolerance in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105355"}}